Medikaloka Hermina PT

JK:HEAL Indonesia Medical Care Facilities
Market Cap
$1.22 Billion
Rp19.82 Trillion IDR
Market Cap Rank
#8167 Global
#36 in Indonesia
Share Price
Rp1290.00
Change (1 day)
-0.77%
52-Week Range
Rp935.00 - Rp1760.00
All Time High
Rp971874.91
Categories
Companies in Indonesia Medical Care Facilities
About

PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more

Medikaloka Hermina PT (HEAL) - Net Assets

Latest net assets as of June 2025: Rp7.01 Trillion IDR

Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has net assets worth Rp7.01 Trillion IDR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp11.92 Trillion) and total liabilities (Rp4.91 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Rp7.01 Trillion
% of Total Assets 58.83%
Annual Growth Rate 22.31%
5-Year Change 73.45%
10-Year Change N/A
Growth Volatility 44.96

Medikaloka Hermina PT - Net Assets Trend (2015–2024)

This chart illustrates how Medikaloka Hermina PT's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Medikaloka Hermina PT (2015–2024)

The table below shows the annual net assets of Medikaloka Hermina PT from 2015 to 2024.

Year Net Assets Change
2024-12-31 Rp5.87 Trillion +12.85%
2023-12-31 Rp5.20 Trillion +10.95%
2022-12-31 Rp4.69 Trillion +6.82%
2021-12-31 Rp4.39 Trillion +29.69%
2020-12-31 Rp3.38 Trillion +22.35%
2019-12-31 Rp2.76 Trillion +16.66%
2018-12-31 Rp2.37 Trillion +147.74%
2017-12-31 Rp956.53 Billion -24.08%
2016-12-31 Rp1.26 Trillion +31.58%
2015-12-31 Rp957.59 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Medikaloka Hermina PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 2257.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings Rp2.83 Trillion 63.49%
Common Stock Rp307.32 Billion 6.90%
Other Comprehensive Income Rp-470.59 Billion -10.57%
Other Components Rp1.79 Trillion 40.17%
Total Equity Rp4.45 Trillion 100.00%

Medikaloka Hermina PT Competitors by Market Cap

The table below lists competitors of Medikaloka Hermina PT ranked by their market capitalization.

Company Market Cap
Jointo Energy Investment Co Ltd Hebei
SHE:000600
 		$810.91 Million
Celltrion Pharm Inc
KQ:068760
 		$811.10 Million
Mach Natural Resources LP
NYSE:MNR
 		$812.07 Million
Sunshine Insurance Group Company Limited
F:E57
 		$812.67 Million
SENSIRION HOLDING
F:1Q3
 		$810.77 Million
Daktronics Inc
NASDAQ:DAKT
 		$810.63 Million
LG Household & Healthcare Ltd Pref
KO:051905
 		$810.60 Million
Transportadora de Gas del Norte SA Class C
BA:TGNO4
 		$810.45 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medikaloka Hermina PT's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 3,869,118,000,000 to 4,451,977,000,000, a change of 582,859,000,000 (15.1%).
  • Net income of 535,942,000,000 contributed positively to equity growth.
  • Dividend payments of 126,565,000,000 reduced retained earnings.
  • Share repurchases of 167,650,000,000 reduced equity.
  • New share issuances of 167,650,000,000 increased equity.
  • Other comprehensive income decreased equity by 43,186,000,000.
  • Other factors increased equity by 216,668,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Rp535.94 Billion +12.04%
Dividends Paid Rp126.56 Billion -2.84%
Share Repurchases Rp167.65 Billion -3.77%
Share Issuances Rp167.65 Billion +3.77%
Other Comprehensive Income Rp-43.19 Billion -0.97%
Other Changes Rp216.67 Billion +4.87%
Total Change Rp- 15.06%

Book Value vs Market Value Analysis

This analysis compares Medikaloka Hermina PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.30x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 20.51x to 4.30x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-12-31 Rp62.88 Rp1290.00 x
2016-12-31 Rp82.85 Rp1290.00 x
2017-12-31 Rp35.96 Rp1290.00 x
2018-12-31 Rp132.95 Rp1290.00 x
2019-12-31 Rp142.31 Rp1290.00 x
2020-12-31 Rp171.44 Rp1290.00 x
2021-12-31 Rp219.27 Rp1290.00 x
2022-12-31 Rp237.06 Rp1290.00 x
2023-12-31 Rp262.97 Rp1290.00 x
2024-12-31 Rp299.96 Rp1290.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medikaloka Hermina PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.04%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.96%
  • • Asset Turnover: 0.64x
  • • Equity Multiplier: 2.38x
  • Recent ROE (12.04%) is below the historical average (13.93%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 2.13% 1.13% 0.96x 1.97x Rp-71.20 Billion
2016 5.20% 2.77% 0.89x 2.10x Rp-57.24 Billion
2017 21.47% 3.64% 0.80x 7.37x Rp52.12 Billion
2018 6.67% 4.07% 0.73x 2.24x Rp-62.21 Billion
2019 16.02% 9.47% 0.72x 2.35x Rp129.20 Billion
2020 25.30% 14.62% 0.69x 2.49x Rp390.43 Billion
2021 30.47% 17.11% 0.77x 2.32x Rp669.06 Billion
2022 8.68% 6.09% 0.65x 2.21x Rp-45.49 Billion
2023 11.30% 7.56% 0.66x 2.28x Rp50.43 Billion
2024 12.04% 7.96% 0.64x 2.38x Rp90.74 Billion

Industry Comparison

This section compares Medikaloka Hermina PT's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $3,878,162,575,369
  • Average return on equity (ROE) among peers: 27.56%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Medikaloka Hermina PT (HEAL) Rp7.01 Trillion 2.13% 0.70x $810.80 Million
Bundamedik Tbk PT (BMHS) $665.59 Billion 4.71% 1.10x $23.76 Million
Metro Healthcare Indonesia (CARE) $3.30 Trillion 0.18% 0.28x $411.41 Million
Lippo Karawaci Tbk (LPKR) $23.57 Trillion -40.88% 1.20x $179.43 Million
Mitra Keluarga Karyasehat Tbk PT (MIKA) $3.28 Trillion 17.29% 0.13x $602.27 Million
PT Murni Sadar Tbk (MTMH) $50.49 Billion 4.95% 14.96x $27.98 Million
Famon Awal Bros Sedaya (PRAY) $3.13 Trillion 6.43% 0.62x $52.90 Million
Royal Prima PT (PRIM) $722.89 Million 252.77% 36.50x $3.23 Million
PT Charlie Hospital Semarang Tbk (RSCH) $150.46 Billion -0.74% 0.03x $11.66 Million
Kedoya Adyaraya Tbk PT (RSGK) $751.16 Billion 3.35% 0.10x $3.08 Million